Literature DB >> 12088290

Use and evaluation of critical pathways in hospitals.

Jonathan Darer1, Peter Pronovost, Eric B Bass.   

Abstract

CONTEXT: Although hospitals have devoted substantial resources to critical pathways, it is not known whether they routinely evaluate the clinical or economic effects of these pathways.
OBJECTIVE: To determine how use and evaluation of critical pathways differ between academic and community hospitals.
DESIGN: Cross-sectional survey. PARTICIPANTS: Hospitals participating in consortia for improving quality of care associated with the Institute of Health Care Improvement and the VHA, Inc. (formerly known as the Voluntary Hospitals of America, Inc.). Hospital administrators at 41 hospitals completed the survey (71% response rate), representing 13 academic medical centers, 13 community teaching hospitals, and 15 community hospitals. MEASURES: Use of critical pathways and measurement of clinical and economic outcomes of pathways.
RESULTS: The median number of adult critical pathways used by academic hospitals, community teaching hospitals, and community hospitals was 25, 18, and 3, respectively. The most common pathways were community-acquired pneumonia, total hip or knee replacement, and stroke or transient ischemic attack. The percentage of hospitals with pathways dedicating staff to manage them was 78% for academic hospitals, 22% for community teaching hospitals, and 14% for community hospitals (P = 0.02). Evaluation practices varied widely among hospitals with pathways. Measures assessed included monitoring length of stay (85%), total hospital costs (74%), in-hospital mortality (62%), infectious complications (53%), readmission rates (47%), functional status (18%), and adverse drug events (15%).
CONCLUSION: The use of critical pathways varies substantially among hospitals participating in quality improvement consortia. Use was highest in academic centers and lowest in community hospitals. Many hospitals with pathways do not track important clinical outcomes as part of their evaluation practices.

Entities:  

Mesh:

Year:  2002        PMID: 12088290

Source DB:  PubMed          Journal:  Eff Clin Pract        ISSN: 1099-8128


  9 in total

Review 1.  [Clinical pathway "total knee arthroplasty"].

Authors:  C Lüring; J Grifka; S Kirschner
Journal:  Orthopade       Date:  2010-08       Impact factor: 1.087

2.  [Clinical pathway for total knee arthroplasty. I: Pathway conception and effect on functional quality of results].

Authors:  S Kirschner; J Lützner; K P Günther; M E Gonska; K Reinicke; F Krummenauer
Journal:  Orthopade       Date:  2010-09       Impact factor: 1.087

3.  Critical pathway effectiveness: assessing the impact of patient, hospital care, and pathway characteristics using qualitative comparative analysis.

Authors:  Sydney M Dy; Pushkal Garg; Dorothy Nyberg; Patricia B Dawson; Peter J Pronovost; Laura Morlock; Haya Rubin; Albert W Wu
Journal:  Health Serv Res       Date:  2005-04       Impact factor: 3.402

Review 4.  Pathway management in ambulatory wound care: defining local standards for quality improvement and interprofessional care.

Authors:  Peter Hensen; Huong-Lan Ma; Thomas A Luger; Norbert Roeder; Martin Steinhoff
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

Review 5.  [Clinical pathways. A useful steering instrument or a limitation for medical treatment?].

Authors:  S Kirschner; W-C Witzleb; M Eberlein-Gonska; F Krummenauer; K-P Günther
Journal:  Orthopade       Date:  2007-06       Impact factor: 1.087

6.  DRUGS System Improving the Effects of Clinical Pathways: A Systematic Study.

Authors:  Shan Wang; Xiaohe Zhu; Xian Zhao; Yang Lu; Zhifu Yang; Xiaoliang Qian; Weiwei Li; Lixiazi Ma; Huning Guo; Jingwen Wang; Aidong Wen
Journal:  J Med Syst       Date:  2015-12-10       Impact factor: 4.460

7.  Existence and role of standard operating procedures in the emergency department : A national online survey.

Authors:  Benjamin Lucas; Wiebke Schirrmeister; Gerald Pliske; Michael Leenen; Felix Walcher; Carsten Kopschina
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-12-06       Impact factor: 0.840

8.  Cost effectiveness of total knee arthroplasty from a health care providers' perspective before and after introduction of an interdisciplinary clinical pathway--is investment always improvement?

Authors:  Frank Krummenauer; Klaus-Peter Guenther; Stephan Kirschner
Journal:  BMC Health Serv Res       Date:  2011-12-14       Impact factor: 2.655

9.  Effects of clinical pathways in the joint replacement: a meta-analysis.

Authors:  A Barbieri; K Vanhaecht; P Van Herck; W Sermeus; F Faggiano; S Marchisio; M Panella
Journal:  BMC Med       Date:  2009-07-01       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.